Ionis Pharmaceuticals, Inc. (IONS) Q2 2023 Earnings Call Transcript


Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Conference Call August 9, 2023 11:30 AM ET

Company Participants

Wade Walke – SVP, IR

Brett Monia – CEO

Richard Geary – Chief Development Officer

Beth Hougen – CFO

Onaiza Cadoret – Chief Global Product Strategy & Operations Officer

Eugene Schneider – Chief Clinical Development Officer

Eric Swayze – EVP, Research

Conference Call Participants

Myles Minter – William Blair

Robert Finke – Guggenheim Partners

Kostas Biliouris – BMO Capital Markets

Mike Ulz – Morgan Stanley

Yanan Zhu – Wells Fargo

David Lebowitz – Citigroup Inc.

Allison Bratzel – Piper Sandler

Paul Matteis – Stifel

Yaron Werber – TD Cowen

Luca Issi – RBC Capital Markets

Yale Jen – Laidlaw & Company

Joseph Stringer – Needham & Company

Operator

Good morning, and welcome to Ionis’ Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.

At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin.

Wade Walke

Thank you, MJ. Before we begin, I encourage everyone to go to the Investors section of the Ionis website to view the press release and related financial tables we will be discussing today, including a reconciliation of GAAP to non-GAAP financials. We believe non-GAAP financial results better represent the economics of our business and how we manage our business. We’ve also posted slides on our website that accompany today’s call.

With me this morning are Brett Monia, our Chief Executive Officer; Richard Geary, Chief Development Officer; and Beth Hougen, our Chief Financial Officer. Eric Swayze, Executive Vice President of Research; Eugene Schneider, Chief Clinical Development Officer; and Onaiza Cadoret, Chief Global Product Strategy and Operations Officer, will also join us for the Q&A portion of the call.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *